FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer.On April 7, 2021, the Food and Drug Administration granted regular approval to sacituzumab govitecan (Trodelvy, Immunomedics Inc.) for patients with unresectable locally advanced or metastatic more...
If you are looking for purchasing qualitative and cost efficient Rituximab Injection, contact us today! The raw material used in the manufacturing of products are tested stringently by the experts to make certain that the final product is of premium quality and free from any kindmore...